Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients43

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients29

Views

Views
February 20250
March 202515
April 20252
May 20250
June 20250
July 202512
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Brazil6
United States2
Argentina1
Canada1
Germany1
Spain1
Jamaica1
South Africa1
 

Top cities views

Views
São Paulo2
Araguaína1
Belleville1
Brasília1
Council Bluffs1
Hamburg1
Jacksonville1
Johannesburg1
Marília1
Montego Bay1